MENU

CRVS Corvus Pharmaceuticals Forecast, Technical & Fundamental Analysis

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function... Show more

CRVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CRVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRVS is expected to report earnings to rise 10.53% to -20 cents per share on November 03

Corvus Pharmaceuticals CRVS Stock Earnings Reports
Q3'26
Est.
$-0.21
Q2'26
Missed
by $0.04
Q1'26
Est.
$-0.15
Q4'25
Missed
by $0.02
Q3'25
Beat
by $0.01
The last earnings report on August 06 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 662.03K shares outstanding, the current market capitalization sits at 879.06M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGG2.470.12
+5.11%
Osisko Gold Group Inc
ONL2.250.06
+2.74%
Orion Properties Inc
PFG110.131.56
+1.44%
Principal Financial Group
SLG50.410.27
+0.54%
SL Green Realty Corp
WXM2.89-0.06
-2.03%
WF International Limited

CRVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been closely correlated with ACRS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRVS jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-0.76%
ACRS - CRVS
66%
Closely correlated
+1.07%
RZLT - CRVS
42%
Loosely correlated
-0.91%
IMNM - CRVS
37%
Loosely correlated
-0.56%
AMLX - CRVS
36%
Loosely correlated
-0.40%
OVID - CRVS
35%
Loosely correlated
-0.23%
More

Groups containing CRVS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-0.76%
CRVS
(2 stocks)
99%
Closely correlated
+0.39%
A.I. Advisor
published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Industry
Pharmaceuticals Major
Address
901 Gateway Boulevard, Third Floor
Phone
+1 650 900-4520
Employees
37
Web
https://www.corvuspharma.com
Corvus Pharmaceuticals (CRVS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com